Spravato (Esketamine) Nasal Spray

Spravato, containing esketamine, is an FDA-approved nasal spray specifically designed for adults with treatment-resistant depression (TRD) and depressive symptoms in Major Depressive Disorder (MDD) with acute suicidal ideation or behavior. As a product from Janssen Pharmaceuticals, Spravato represents a significant advancement in mental health treatment. LyfeUnit offers access to pharmaceutical-grade Spravato, supporting clinics and patients in their journey towards mental well-being. Learn more about its targeted action and clinical applications. Spravato Online Buy